The Use of CGMS to Detect Alterations of Blood Glucose in Thalassemic Patients

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

November 30, 2016

Conditions
DiabetesPrediabetesB-Thalassemia
Interventions
DEVICE

insulin pump/CGMS

"A-Continuous glucose monitoring system (CGMS) : A glucometer will be given to each patient and will be asked to measure blood glucose before meals and snacks and record the valus in the CGMS for better calibration (Khammar A et al., 2009).~B-Therapeutic intervention:~Thalassemia patients who proved to have diabetes according to the ADA criteria will be subjected to~• Insulin pump will be tried in each diabetic thalassemic patient versus conventional insulin therapy(Bruttomesso D et al., 2009)."

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03591900 - The Use of CGMS to Detect Alterations of Blood Glucose in Thalassemic Patients | Biotech Hunter | Biotech Hunter